BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 11956149)

  • 1. Binding properties of insulin-like growth factor binding protein-3 (IGFBP-3), IGFBP-3 N- and C-terminal fragments, and structurally related proteins mac25 and connective tissue growth factor measured using a biosensor.
    Vorwerk P; Hohmann B; Oh Y; Rosenfeld RG; Shymko RM
    Endocrinology; 2002 May; 143(5):1677-85. PubMed ID: 11956149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) functions as an IGF-reversible inhibitor of IGFBP-4 proteolysis.
    Fowlkes JL; Serra DM; Rosenberg CK; Thrailkill KM
    J Biol Chem; 1995 Nov; 270(46):27481-8. PubMed ID: 7499205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily.
    Kim HS; Nagalla SR; Oh Y; Wilson E; Roberts CT; Rosenfeld RG
    Proc Natl Acad Sci U S A; 1997 Nov; 94(24):12981-6. PubMed ID: 9371786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of insulin-like growth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-I receptor signaling.
    Devi GR; Yang DH; Rosenfeld RG; Oh Y
    Endocrinology; 2000 Nov; 141(11):4171-9. PubMed ID: 11089550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding properties and distribution of insulin-like growth factor binding protein-related protein 3 (IGFBP-rP3/NovH), an additional member of the IGFBP Superfamily.
    Burren CP; Wilson EM; Hwa V; Oh Y; Rosenfeld RG
    J Clin Endocrinol Metab; 1999 Mar; 84(3):1096-103. PubMed ID: 10084601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor (IGF)-binding protein-4 proteolytic degradation in bovine, equine, and porcine preovulatory follicles: regulation by IGFs and heparin-binding domain-containing peptides.
    Mazerbourg S; Zapf J; Bar RS; Brigstock DR; Monget P
    Biol Reprod; 2000 Aug; 63(2):390-400. PubMed ID: 10906042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7. Recombinant human mac25 protein specifically binds IGF-I and -II.
    Oh Y; Nagalla SR; Yamanaka Y; Kim HS; Wilson E; Rosenfeld RG
    J Biol Chem; 1996 Nov; 271(48):30322-5. PubMed ID: 8939990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D.
    Claussen M; Kübler B; Wendland M; Neifer K; Schmidt B; Zapf J; Braulke T
    Endocrinology; 1997 Sep; 138(9):3797-803. PubMed ID: 9275067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity of human insulin-like growth factor (IGF) binding protein-2 fragments in plasma: primary structure, IGF-binding properties, and disulfide bonding pattern.
    Mark S; Kübler B; Höning S; Oesterreicher S; John H; Braulke T; Forssmann WG; Ständker L
    Biochemistry; 2005 Mar; 44(9):3644-52. PubMed ID: 15736974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino- and carboxyl-terminal fragments of insulin-like growth factor (IGF) binding protein-3 cooperate to bind IGFs with high affinity and inhibit IGF receptor interactions.
    Payet LD; Wang XH; Baxter RC; Firth SM
    Endocrinology; 2003 Jul; 144(7):2797-806. PubMed ID: 12810533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs.
    Oh Y; Müller HL; Lee DY; Fielder PJ; Rosenfeld RG
    Endocrinology; 1993 Mar; 132(3):1337-44. PubMed ID: 7679979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contributions of the N- and C-terminal domains of IGF binding protein-6 to IGF binding.
    Headey SJ; Leeding KS; Norton RS; Bach LA
    J Mol Endocrinol; 2004 Oct; 33(2):377-86. PubMed ID: 15525596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosensor measurement of the binding of insulin-like growth factors I and II and their analogues to the insulin-like growth factor-binding protein-3.
    Heding A; Gill R; Ogawa Y; De Meyts P; Shymko RM
    J Biol Chem; 1996 Jun; 271(24):13948-52. PubMed ID: 8662901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. Insulin-like growth factor dependence and biological studies.
    Conover CA; Kiefer MC; Zapf J
    J Clin Invest; 1993 Mar; 91(3):1129-37. PubMed ID: 7680662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-binding characteristics of recombinant amino- and carboxyl-terminal fragments of human insulin-like growth factor-binding protein-3.
    Galanis M; Firth SM; Bond J; Nathanielsz A; Kortt AA; Hudson PJ; Baxter RC
    J Endocrinol; 2001 Apr; 169(1):123-33. PubMed ID: 11250653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosensor measurement of the interaction kinetics between insulin-like growth factors and their binding proteins.
    Wong MS; Fong CC; Yang M
    Biochim Biophys Acta; 1999 Jul; 1432(2):293-301. PubMed ID: 10407151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 30-kDa fragment of insulin-like growth factor (IGF) binding protein-3 in human pregnancy serum with strongly reduced IGF-I binding.
    Ahlsén M; Carlsson-Skwirut C; Jonsson AP; Cederlund E; Bergman T; Bang P
    Cell Mol Life Sci; 2007 Jul; 64(14):1870-80. PubMed ID: 17593323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix.
    Arai T; Busby W; Clemmons DR
    Endocrinology; 1996 Nov; 137(11):4571-5. PubMed ID: 8895319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of biotinylated forms of insulin-like growth factor-1: topographical evaluation of the IGF-1/IGFBP-2 AND IGFBP-3 interface.
    Robinson SA; Rosenzweig SA
    Biochemistry; 2004 Sep; 43(36):11533-45. PubMed ID: 15350139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial IGF affinity of circulating N- and C-terminal fragments of human insulin-like growth factor binding protein-4 (IGFBP-4) and the disulfide bonding pattern of the C-terminal IGFBP-4 domain.
    Ständker L; Braulke T; Mark S; Mostafavi H; Meyer M; Höning S; Giménez-Gallego G; Forssmann WG
    Biochemistry; 2000 May; 39(17):5082-8. PubMed ID: 10819974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.